Enzo Biochem, Inc.

NYSE:ENZ   3:59:50 PM EDT
2.02
+0.02 (+1.00%)
Earnings Announcements

Enzo Biochem Reports Third Quarter Fiscal 2022 Results And Provides Leadership And Corporate Updates Including Engagement Of Jefferies As Financial Advisor

Published: 06/09/2022 21:29 GMT
Enzo Biochem, Inc. (ENZ) - Enzo Biochem Reports Third Quarter Fiscal 2022 Results and Provides Leadership and Corporate Updates Including Engagement of Jefferies As Financial Advisor.
Q3 GAAP Loss per Share $0.10.
Q3 Revenue Fell 20 Percent to $26.2 Million.
Cash and Cash Equivalents, Restricted Cash and Marketable Securities Totaled $32.1 Million As of April 30, 2022.